Clinical Research Directory
Browse clinical research sites, groups, and studies.
Washed Microbiota Transplantation for Allergic Rhinitis
Sponsor: The Second Hospital of Nanjing Medical University
Summary
Allergic rhinitis (AR) is characterized by sneezing, nasal congestion, nasal itching and nasal leakage and is caused by immunoglobulin E (IgE)-mediated reactions to inhaled allergens. Increasing evidence showed that gut microbiota could influence the development of AR, and we found that washed microbiota transplantation (WMT) could improve nasal symptoms in clinical practice. This clinical trial aims to evaluate the efficacy and safety of WMT for AR.
Official title: Efficacy and Safety of Washed Microbiota Transplantation for Allergic Rhinitis: A Randomized, Double-blind, Placebo-controlled Study
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2024-06-01
Completion Date
2029-10-01
Last Updated
2024-05-07
Healthy Volunteers
No
Conditions
Interventions
Washed Microbiota Transplantation
Patients take four capsules containing washed microbiota once a day for five consecutive days
Placebo
Patients take four capsules in the same packaging as the experimental group once a day for five consecutive days
Locations (1)
Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China